MolNFT v1 · #99680 · protein
BCL_2-navitoclax analog (with indole) complex
4MAN · Apoptosis regulator BCL-2: “BCL_2-navitoclax analog (with indole) complex”. X-ray diffraction, 1 ligand (1Y1), 6 pockets (best druggability 0.54). MolNFT v1 #99680 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4MAN
- Type
- protein
- Length
- 272 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Apoptosis regulator BCL-2
- UniProt
- P10415
- Ligands
- 1Y1
- Pockets
- 6 · best druggability 0.54
Structure
x-ray diffraction · 1 distinct chain · 76% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Apoptosis regulator BCL-2 | protein | 136 | 76% helix, 0% strand | P10415 |
Ligands and binding sites
- 1Y1 · 4-[4-({4'-chloro-3-[2-(dimethylamino)ethoxy]biphenyl-2-yl}methyl)piperazin-1-yl]-2-(1H-indol-5-yloxy)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)benzamide · ligand · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 243 | 0.54 | 0.77 | 28 | empty |
| 2 | 113 | 0.49 | 0.80 | 15 | empty |
| 3 | 115 | 0.49 | 0.80 | 16 | empty |
| 4 | 60 | 0.38 | 0.80 | 14 | empty |
| 5 | 56 | 0.38 | 0.80 | 14 | empty |
Interfaces
1 interface between chains.
- A–B · 245 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P10415
- Elsewhere: RCSB PDB 4MAN · PDBe 4MAN · UniProt P10415
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.